Haemonetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.

CEO

Christopher A. Simon

CEOChristopher A. Simon

Employees

3,023

Employees3,023

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

1971

Founded1971

Employees

3,023

Employees3,023

HAE Key Statistics

Market cap

2.42B

Market cap2.42B

Price-Earnings ratio

15.19

Price-Earnings ratio15.19

Dividend yield

—

Dividend yield—

Average volume

728.91K

Average volume728.91K

High today

$50.67

High today$50.67

Low today

$49.24

Low today$49.24

Open price

$49.60

Open price$49.60

Volume

795.50K

Volume795.50K

52 Week high

$94.99

52 Week high$94.99

52 Week low

$47.32

52 Week low$47.32

HAE News

Nasdaq 1d

Interesting HAE Put And Call Options For June 2026

Investors in Haemonetics Corp. (Symbol: HAE) saw new options begin trading today, for the June 2026 expiration. One of the key inputs that goes into the price a...

Simply Wall St 4d

Should US-China Trade Volatility Prompt a Rethink of Haemonetics' Supply Chain Strategy?

Haemonetics Corporation recently announced plans to release its second quarter fiscal year 2026 financial results and host a conference call with investors on N...

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

9.1%

Sell

9.1%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.